Hruz P - Search Results

1

Noninvasive Disease Assessment in Eosinophilic Esophagitis With Fractionated Exhaled Nitric Oxide, Blood, and Fecal Biomarkers.

Göldi A, Kaymak T, Esposito L, Lehmann A, Negoias S, Tamm M, Niess JH, Hruz P. Göldi A, et al. Among authors: hruz p. J Clin Gastroenterol. 2024 Sep 2. doi: 10.1097/MCG.0000000000002068. Online ahead of print. J Clin Gastroenterol. 2024. PMID: 39212998

2

The Interleukin-20 Cytokines in Intestinal Diseases.

Niess JH, Hruz P, Kaymak T. Niess JH, et al. Among authors: hruz p. Front Immunol. 2018 Jun 18;9:1373. doi: 10.3389/fimmu.2018.01373. eCollection 2018. Front Immunol. 2018. PMID: 29967613 Free PMC article. Review.

3

Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients.

Kaymak T, Moriconi F, Niess JH, Beglinger C, Hruz P. Kaymak T, et al. Among authors: hruz p. Inflamm Intest Dis. 2018 Mar;2(3):171-179. doi: 10.1159/000486676. Epub 2018 Feb 21. Inflamm Intest Dis. 2018. PMID: 30018967 Free PMC article.

4

The Copper/Zinc Ratio Correlates With Markers of Disease Activity in Patients With Inflammatory Bowel Disease.

Schneider T, Caviezel D, Ayata CK, Kiss C, Niess JH, Hruz P. Schneider T, et al. Among authors: hruz p. Crohns Colitis 360. 2020 Jan;2(1):otaa001. doi: 10.1093/crocol/otaa001. Epub 2020 Jan 23. Crohns Colitis 360. 2020. PMID: 32551440 Free PMC article.

5

Immune system and microbiome in the esophagus: implications for understanding inflammatory diseases.

Kaymak T, Hruz P, Niess JH. Kaymak T, et al. Among authors: hruz p. FEBS J. 2022 Aug;289(16):4758-4772. doi: 10.1111/febs.16103. Epub 2021 Jul 13. FEBS J. 2022. PMID: 34213831 Free PMC article. Review.

6

High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease Patients.

Sutter M, Hruz P, Niess JH. Sutter M, et al. Among authors: hruz p. Inflamm Intest Dis. 2021 Aug 26;6(3):165-174. doi: 10.1159/000518264. eCollection 2021 Sep. Inflamm Intest Dis. 2021. PMID: 34722646 Free PMC article.

7

IL-20 subfamily cytokines impair the oesophageal epithelial barrier by diminishing filaggrin in eosinophilic oesophagitis.

Kaymak T, Kaya B, Wuggenig P, Nuciforo S, Göldi A; Swiss EoE Cohort Study Group (SEECS); Oswald F, Roux J, Noti M, Melhem H, Hruz P, Niess JH. Kaymak T, et al. Among authors: hruz p. Gut. 2023 May;72(5):821-833. doi: 10.1136/gutjnl-2022-327166. Epub 2022 May 25. Gut. 2023. PMID: 35613844 Free PMC article.

8

Amoebic Liver Abscess in Crohn Disease Treated With Ustekinumab.

Rybinski F, Weisser M, Niess JH, Hruz P. Rybinski F, et al. Among authors: hruz p. Inflamm Bowel Dis. 2020 Jun 18;26(7):e68. doi: 10.1093/ibd/izaa101. Inflamm Bowel Dis. 2020. PMID: 32405649 No abstract available.

9

[The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease].

Müller A, Bilger SS, Göldi A, Meinlschmidt G, Rueter F, Kappes A, Hruz P, Meier CA, Niess JH. Müller A, et al. Among authors: hruz p. Z Gastroenterol. 2022 Jun;60(6):911-926. doi: 10.1055/a-1482-8642. Epub 2021 Jun 24. Z Gastroenterol. 2022. PMID: 34169492 German.

10

High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease.

Caviezel D, Maissen S, Niess JH, Kiss C, Hruz P. Caviezel D, et al. Among authors: hruz p. Inflamm Intest Dis. 2018 Jul;2(4):200-210. doi: 10.1159/000489010. Epub 2018 Jun 28. Inflamm Intest Dis. 2018. PMID: 30221147 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters